A randomized investigator-blind parallel-group study to assess efficacy and safety of azelaic acid 15% gel vs. adapalene 0.1% gel in the treatment and maintenance treatment of female adult acne

Journal of the European Academy of Dermatology and Venereology

Volumn 29, Issue 4, 2015, Pages 789-796

  Thielitz, A ^a   Lux, A ^a   Wiede, A ^a   Kropf, S ^a   Papakonstantinou, E ^a   Gollnick, H ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; AZELAIC ACID; DERMATOLOGICAL AGENT; DICARBOXYLIC ACID; GEL;

ACNE; ADULT; ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DERMATOLOGY LIFE QUALITY INDEX; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ERYTHEMA; FEMALE; GEL; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT DURATION; TREATMENT OUTCOME; ACNE VULGARIS; COMPARATIVE STUDY; MAINTENANCE CHEMOTHERAPY; PROCEDURES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ACNE VULGARIS; ADAPALENE; ADULT; DERMATOLOGIC AGENTS; DICARBOXYLIC ACIDS; FEMALE; GELS; HUMANS; MAINTENANCE CHEMOTHERAPY; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; YOUNG ADULT;

EID: 84925630825     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12823     Document Type: Article

References (30)

1. Gollnick HP, Finlay AY, Shear N,. Can we define acne as a chronic disease? If so, how and when? Am J Clin Dermatol 2008; 9: 279-284.
2. Preneau S, Dreno B,. Female acne-a different subtype of teenager acne? J Eur Acad Dermatol Venereol 2012; 26: 277-282.
3. Thiboutot D, Gollnick H, Bettoli V, et al,. New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group. J Am Acad Dermatol 2009; 60: S1-S50.
4. Yentzer BA, Hick J, Reese EL, et al,. Acne vulgaris in the United States: a descriptive epidemiology. Cutis 2010; 86: 94-99.
5. Goulden V, Clark SM, Cunliffe WJ,. Post-adolescent acne: a review of clinical features. Br J Dermatol 1997; 136: 66-70.
6. Goulden V, Stables GI, Cunliffe WJ,. Prevalence of facial acne in adults. J Am Acad Dermatol 1999; 41: 577-580.
7. Collier CN, Harper JC, Cafardi JA, et al,. The prevalence of acne in adults 20 years and older. J Am Acad Dermatol 2008; 58: 56-59.
8. Poli F, Dreno B, Verschoore M,. An epidemiological study of acne in female adults: results of a survey conducted in France. J Eur Acad Dermatol Venereol 2001; 15: 541-545.
9. Dreno B, Layton A, Zouboulis CC, et al,. Adult female acne: a new paradigm. J Eur Acad Dermatol Venereol 2013; 27: 1063-1070.
10. Rivera R, Guerra A,. Management of acne in women over 25 years of age. Actas Dermosifiliogr 2009; 100: 33-37.
11. Goulden V, Clark SM, McGeown C, Cunliffe WJ,. Treatment of acne with intermittent isotretinoin. Br J Dermatol 1997; 137: 106-108.
12. Shaw JC, White LE,. Persistent acne in adult women. Arch Dermatol 2001; 137: 1252-1253.
13. Thielitz A, Sidou F, Gollnick H,. Control of microcomedone formation throughout a maintenance treatment with adapalene gel, 0.1%. J Eur Acad Dermatol Venereol 2007; 21: 747-753.
14. Thielitz A, Abdel-Naser MB, Fluhr JW, et al,. Topical retinoids in acne-an evidence-based overview. J Dtsch Dermatol Ges 2008; 6: 1023-1031.
15. Thiboutot DM, Gollnick HP,. Treatment considerations for inflammatory acne: clinical evidence for adapalene 0.1% in combination therapies. J Drugs Dermatol 2006; 5: 785-794.
16. Thiboutot DM, Shalita AR, Yamauchi PS, et al,. Adapalene gel, 0.1%, as maintenance therapy for acne vulgaris: a randomized, controlled, investigator-blind follow-up of a recent combination study. Arch Dermatol 2006; 142: 597-602.
17. Thiboutot DM, Fleischer AB, Del Rosso JQ, Rich P,. A multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance monotherapy. J Drugs Dermatol 2009; 8: 639-648.
18. Gollnick HP, Graupe K, Zaumseil RP,. Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne. Eur J Dermatol 2001; 11: 538-544.
19. Gollnick HP, Graupe K, Zaumseil RP,. Azelaic acid 15% gel in the treatment of acne vulgaris. Combined results of two double-blind clinical comparative studies. J Dtsch Dermatol Ges 2004; 2: 841-847.
20. Kircik LH,. Efficacy and safety of azelaic acid (AzA) gel 15% in the treatment of post-inflammatory hyperpigmentation and acne: a 16-week, baseline-controlled study. J Drugs Dermatol 2011; 10: 586-590.
21. Dreno B, Castell A, Tsankov N, et al,. Interest of the association retinaldehyde/glycolic acid in adult acne. J Eur Acad Dermatol Venereol 2009; 23: 529-532.
22. Gollnick H, Albring M, Brill K,. The effectiveness of oral cyproterone acetate in combination with ethinylestradiol in acne tarda of the facial type. Ann Endocrinol (Paris) 1999; 60: 157-166.
23. Rademaker M, Wishart JM, Birchall NM,. Isotretinoin 5 mg daily for low-grade adult acne vulgaris-a placebo-controlled, randomized double-blind study. J Eur Acad Dermatol Venereol 2014; 28: 747-754.
24. Shaw JC,. Low-dose adjunctive spironolactone in the treatment of acne in women: a retrospective analysis of 85 consecutively treated patients. J Am Acad Dermatol 2000; 43: 498-502.
25. O'Brien SC, Lewis KB, Cunliffe WJ,. The leeds revised acne grading system. J Dermatol Treatment 1998; 9: 215-220.
26. Pocock SJ, Simon R,. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 1975; 31: 103-115.
27. Finlay AY, Khan GK,. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216.
28. Seukeran DC, Cunliffe WJ,. Acne vulgaris in the elderly: the response to low-dose isotretinoin. Br J Dermatol 1998; 139: 99-101.
29. Mastrofrancesco A, Ottaviani M, Aspite N, et al,. Azelaic acid modulates the inflammatory response in normal human keratinocytes through PPARgamma activation. Exp Dermatol 2010; 19: 813-820.
30. Buerger C, Richter B, Woth K, et al,. Interleukin-1beta interferes with epidermal homeostasis through induction of insulin resistance: implications for psoriasis pathogenesis. J Invest Dermatol 2012; 132: 2206-2214.